PharmaCorp Rx Inc.
PCRX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.73% | -55.99% | 493.89% | 427.61% | 955.12% |
| Total Receivables | 242.15% | 832.02% | -- | -- | -- |
| Inventory | 625.68% | 3,049.75% | -- | -- | -- |
| Prepaid Expenses | 183.23% | 168.83% | 3,100.00% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -69.93% | -45.35% | 561.20% | 476.48% | 979.50% |
|
|
|||||
| Total Current Assets | -69.93% | -45.35% | 561.20% | 476.48% | 979.50% |
| Net Property, Plant & Equipment | 351.09% | 399.55% | -- | -- | -- |
| Long-term Investments | 603.58% | 1,893.12% | -- | -- | -- |
| Goodwill | 603.58% | 1,893.12% | -- | -- | -- |
| Total Other Intangibles | 297.15% | 456.16% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 20.06% | 46.35% | 1,465.83% | 1,292.66% | 1,168.80% |
|
|
|||||
| Total Accounts Payable | 459.79% | 391.72% | 2,147.31% | 2,950.57% | 1,094.43% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 222.50% | 14.76% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 123.53% | -- | -- | -- |
| Total Other Current Liabilities | -- | 123.53% | -- | -- | -- |
| Total Current Liabilities | 406.50% | 295.19% | 2,619.96% | 3,268.00% | 1,454.43% |
|
|
|||||
| Total Current Liabilities | 406.50% | 295.19% | 2,619.96% | 3,268.00% | 1,454.43% |
| Long-Term Debt | 805.21% | -20.88% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.72% | 9.09% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 327.80% | 471.28% | -- | -- | -- |
| Total Liabilities | 358.38% | 195.91% | 7,104.04% | 9,119.43% | 4,777.70% |
|
|
|||||
| Common Stock & APIC | -3.09% | 34.03% | 827.58% | 803.68% | 892.96% |
| Retained Earnings | 9.62% | -20.11% | -38.24% | -83.53% | -249.89% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.48% | 35.16% | 1,290.80% | 1,124.54% | 1,098.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.48% | 35.16% | 1,290.80% | 1,124.54% | 1,098.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -10.38% | 50.40% | -- | -- | -- |
| Total Equity | -2.55% | 35.26% | 1,301.48% | 1,133.52% | 1,108.95% |
|
|
|||||